Skip to content

Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men

Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02969577
Enrollment
38
Registered
2016-11-21
Start date
2017-03-07
Completion date
2020-07-31
Last updated
2021-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Androgen deprivation therapy, ADT

Brief summary

The purpose of this study is to learn if lifestyle changes and counseling along with standard medical care, compared to standard medical care alone, can prevent heart problems and diabetes in men who are receiving ADT for prostate cancer treatment.

Detailed description

Prostate cancer is a very treatable cancer but those treatments can have long-lasting effects. A kind of hormone therapy called Androgen Deprivation Therapy (ADT) is often used along with other treatments like radiation and has been shown to improve survival. However, ADT can have negative effects especially on the heart and metabolism (the body's system for using and storing energy). Participation in this study will last for up to 12 months. The study is looking at two different approaches to treating men who are undergoing ADT: 1. Staying Strong & Healthy Intervention + Usual Care 2. Usual Care All participants will have blood drawn and be asked questions about how they are feeling during their participation. The men in the Staying Strong & Healthy Intervention group will also take part in a diet and exercise program and receive counseling from a member of the study team.

Interventions

BEHAVIORALExercise Program

Participants will have a personal training session at the first visit. A member of the study team will discuss strength training and cardiovascular workouts for them to complete over the first 6 months of the study. A member of the study team will then talk with the participant every week for the first 3 months and monthly afterwards until month 6. Participants will be sent exercise videos and be given recommendations for the exercise program via phone calls and will be tailored to the individual. Videos and recommendations will be sent directly to the participant's smartphone.

BEHAVIORALDiet and Nutrition Coaching

Diet and nutrition coaching session with an overview of resources on the smartphone. Over the first 6 months, participants will receive healthy recipes and nutritional information on the smartphone.

OTHERUsual Care with Attention

Participants will receive the usual care for men undergoing ADT. This includes monitoring blood work and answering questions about how they are feeling. Participants will be directed to the IMPACT website for education materials on prostate cancer.

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with prostate cancer * Starting or have started ADT (oral or injection) for prostate cancer treatment within the last 3 months * Re-initiating ADT after being on holiday for longer than their ADT dosage (e.g. If the man's dosage is every six months and he has been off ADT for more than six he is eligible); * Able to speak and read in English or Spanish * Reachable consistently by telephone * Able to travel to KUMC

Exclusion criteria

* Not diagnosed with prostate cancer * Not receiving or planning to receive ADT for prostate cancer treatment within the last three months * Initiating ADT for prostate cancer prior to the previous 3 months or are not on ADT holiday * Not able to speak and read in English or Spanish * Not reachable consistently by telephone * Not able to travel to the study site for data collection

Design outcomes

Primary

MeasureTime frame
Change in LDLChange from Baseline to Month 12

Secondary

MeasureTime frameDescription
Change in Body Mass Index (BMI)Change from Baseline to Month 6
Change in Lipid ProfileChange from Baseline to Month 6
Change in Waist/Hip CircumferenceChange from Baseline to Month 6
Change in GlucoseChange from Baseline to Month 6
Change in Health Related QualityChange from Baseline to Month 6Quality of life will be measured using the SF-12 and Expanded Prostate Cancer Index Composite. The two are scored together and result in a composite score. Scores can range from 0-100. The higher the score the better the quality of life.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026